Phase III Melanoma interim data read-out | PVCT Message Board Posts

Provectus Biopharmaceuticals, Inc.

  PVCT website
  • Create your FREE account today!

    Username:Up to 23 characters, no spaces or apostrophes allowed.

    Password:6-20 characters.

    Confirm PasswordRetype Your Password.

    Email:You will receive an email to confirm this account,so please enter a valid address (and double cheek for typos!)

    I have read and agree to the InvestorVillage User Agreement.

PVCT   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  24149 of 38097  at  1/14/2016 3:17:46 PM  by


 In response to msg 24147 by  agrossfarm
view thread

Re: Phase III Melanoma interim data read-out

"Our estimated primary completion date is September 2017, and an estimated study completion date of October 2017. When 50 percent of the events required for the primary endpoint have occurred, the Independent Data Monitoring Committee will report an interim assessment of efficacy and safety. So, meaningful clinical data could come as early as the middle of next year, which is halfway through the study, as documented on I stretch the word could, and we will continue to make every effort possible to keep our stockholders and the market updated."
Provectus 2015 Third Quarter Business Update
Eric still maintains that the trial is on track. So, according to this, it's possible to start looking for data within the timelines that PVCT has given until they back off of this statement.  This question will be asked again at the upcoming con call so I'm sure that's when we'll see if Eric wants to back off of this statement.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 190
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Msg # Subject Author Recs Date Posted
24161 Re: Phase III Melanoma interim data read-out agrossfarm 0 1/14/2016 4:14:10 PM

About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2016 All rights reserved. User Agreement
Financial Market Data provided by